Erin Mistry is EVP and Chief Commercial Officer at CorMedix – where she leads the company’s commercial strategy and execution with an expected approval late this year. CorMedix is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions.
Erin brings over 18 years of industry experience at the executive level from consulting to in-house executive management. Prior to joining CorMedix, Erin held roles in health systems, industry and consulting – managing the global P&L for the Value Access practice at Syneos Health. During her career she has worked with and for emerging, mid, and large biopharma across a broad range of therapeutic categories and mentors early-stage companies on commercial viability, reimbursement, and valuation to optimize their portfolio.
Erin holds an undergraduate and Master’s degree in Biomechanical Engineering from North Carolina State University.